Article: A-126 Evaluation of a rapid lateral flow immunoassay (STic Expert® HIT) in Heparin-Induced Thrombocytopenia (HIT)

Article: Updated results of the phase III COLUMBUS trial further solidify BRAF/MEK combinations as standard of care for BRAF-mutated advanced melanoma